Medical Breakthrough Achieved By Biotech Company For Candidiasis

Cidara Therapeutics' REZZAYO Gets Green Light in Europe: A Revolutionary Treatment for Invasive Candidiasis.

The European Union approves rezafungin, a groundbreaking drug for the treatment of invasive candidiasis in adults. This article includes affiliate links.

A significant medical breakthrough has been achieved by Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company dedicated to the discovery, development, and commercialization of novel anti-infe…